Nurses News

 
 

  • Cancer Prognosis Tied to Short-Term Suicide Risk Poorer prognosis after a cancer diagnosis was strongly associated with a higher suicide risk within 6 months of diagnosis, according to an analysis of US registry data.
  • US Life Expectancy Still Lags: What Doctors Can Do Today Learn why American life expectancy has eroded and what you can do with patients to help fix the problem.
  • Link Between Vitamin D Deficiency and Obesity Unclear Debates about the association of vitamin D levels with obesity are ongoing, and confounding factors remain to be elucidated.
  • People of Color Worry Good Health Care Is Tied to Appearance Many people from minority groups brace themselves for insults and judgments before medical appointments, according to a new survey that reaffirms the prevalence of discrimination in US health system.
  • Next Up for PCPs: Managing CKM An AHA presidential advisory introduced the concept of cardiovascular-kidney-metabolic health, with PCPs as key providers.
  • How’s the Food? Rate Your Hospital Cafeteria Historically, hospital cafeterias have not been celebrated for the quality of their cuisine, typically feeding their staff from the same kitchen that prepared patient meals. How would you rate your hospital's cafeteria?
  • Genetic Testing Warranted in Epilepsy of Unknown Origin Benefits of genetic testing in adults with unexplained epilepsy include enrollment in a clinical trial of a relevant gene therapy, connection to families with a similar diagnosis, and peace of mind.
  • The Prospect of a Medication to Treat OSA Is Getting Closer A recent study assessed a combination of aroxybutynin, which has an antimuscarinic effect, and atomoxetine, which has a noradrenergic effect, in treating OSA.
  • Radioimmunotherapy Tops ASCT in R/R Follicular Lymphoma A new trial from Italy challenges a decades-old assumption that autologous stem cell transplant is more effective than radioimmunotherapy for consolidation after follicular lymphoma relapse.
  • MDMA Therapy for Loneliness? Researchers Say It Could Work Studies show the drug can make people more social and less defensive, effects that some say could be harnessed to treat loneliness in therapy.
  • Eli Lilly's Obesity Drug Now Available in US Pharmacies Eli Lilly's recently approved obesity treatment is now available in US pharmacies and could cost customers whose health insurance does not cover the drug $550 a month, or half the list price, the company said on Tuesday.
  • Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly.
  • How the New Outbreak in China Is Hitting Clinics Elsewhere A rise in respiratory illnesses in China, clusters of pneumonia in children, and resistance to common antibiotics have specialists on alert looking for changes locally.
  • 'Hidden Hearing Loss' May Cause Tinnitus: Study Some people who have tinnitus are still able to perform well on standard hearing tests, according to researchers at the Massachusetts Eye and Ear Infirmary.
  • ASH 2023 ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
  • Analysis Supports Link Between Psoriasis and OSA Several hypotheses may explain the connection, such as the presence of inflammatory mediators and nocturnal cytokine secretion, according to the authors.
  • Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
  • Statin Use Remains Low for At-Risk Patients Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.
  • No Benefit of Levothyroxine in Heart Donors New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
  • When Do Older Adults Need CT in the ED After a Fall? A new decision rule could help emergency physicians identify which older adults need CT imaging for head injuries after a fall.
  • An ED Nurse Crosses Busy Freeway to Save a Life When a huge cement truck slams into a freeway retaining wall, an ED nurse on her way home jumps in with no equipment to prevent a bleed-out.
  • How Gender-Affirming Treatment Affects Erythrocytosis Gender-affirming hormone therapy has been associated with a risk for abnormal blood cell elevation, but a new study finds that it is a lower risk than was previously believed.
  • AES 2023 Poverty Tied to Poor Cognition in Patients With Epilepsy Mounting research links poverty and other elements of neighborhood deprivation to worse cognition in people with epilepsy.
  • US Obesity Docs Expect Zepbound to Show Heart Benefit Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy.
  • Launches of Novo Nordisk's Weight-Loss Drug Wegovy Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe and Asia, even as it struggles to keep up with demand.
  • EU Watchdog Seeks More Safety Data From GLP-1 Drugmakers The EU's drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs including Ozempic and Wegovy to further investigate suicidal thoughts in some patients taking them.
  • Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with high rates of side effects such as nausea and vomiting.
  • How Climate Change Is Making the World Sick Heat stress. Lung damage from wildfire smoke. These are just a few of the ways that public health has been impacted and compounded by climate change - a focus for the first time at COP28.
  • EMA Committee Recommends Label Update for Some Decongestants The European Medicines Agency's safety committee on Friday recommended changes to product information for all medicines that contain the ingredient pseudoephedrine to address safety concerns related to neurological and heart-related side effects.
  • NPs Confront Unexpected Delays Opening Private Practices Nurse practitioners have expanded scopes of practice in about half of US states, but payers and collaborating physicians aren't always so quick to jump on board.
  • How Will the Supreme Court Reshape US Opioid Epidemic Relief? The Supreme Court is set on Monday to hear arguments over the legality of a roughly $6 billion bankruptcy settlement involving Purdue Pharma.
  • COVID-19 Shrinks Life Expectancy in S. Korea Babies born in South Korea last year are expected to live 82.7 years, down from 83.6 years in 2021, the statistics agency said on Friday, after life expectancy fell in 2022 for the first time since 1970.
  • Alert FDA Approves Pirtobrutinib for Previously Treated CLL/SLL The approval is the second this year for the reversible, highly selective kinase inhibitor following a January approval in mantle cell lymphoma.
  • Infertility Linked With Slightly Higher Autism Risk in Kids A large study suggests that underlying infertility, and not fertility treatments themselves, may drive the association between parental infertility and autism spectrum disorder in the child.
  • Secondhand Smoke Exposure Linked to Migraine Secondhand smoke exposure is associated with migraine or severe headache, results of a large population-based study show, prompting the researchers to call for increased regulation of tobacco use.
  • AI Aids Type 2 Diabetes Insulin Dosing A patient-facing voice-based conversational artificial intelligence application helped patients with type 2 diabetes optimize their insulin doses.
  • Time to Stop Routine Maintenance Therapy in Myeloma? Physicians may need to rethink maintenance with lenalidomide (Revlimid and generics) for multiple myeloma.
  • Excessive TV-Watching Tied to Greater Risk for Dementia, PD Excessive television-watching is tied to an increased risk for dementia, PD, and depression, whereas a limited amount of nonwork-related computer use is linked to a lower dementia risk.
  • COVID Vax T-Cell Responses Help B-Cell–Deficient Patients The findings demonstrate how vaccine-induced T-cell responses could potentially reduce COVID-19 severity, the authors write.
  • HS: Positive Results Reported With Anti-IL17A/F Therapies One of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies.